SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179022-17-000069
Filing Date
2017-12-08
Accepted
2017-12-08 14:26:11
Documents
1
Period of Report
2017-12-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3486
  Complete submission text file 0001179022-17-000069.txt   5024
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TITAN PHARMACEUTICALS, INC. 400 OYSTER POINT BLVD., STE 505 SAN FRANCISCO CA 94080
Business Address
Rubin Marc (Reporting) CIK: 0001412377 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31791 | Film No.: 171246835